More Articles


The Future of Clinical Trials?

Danielle Barron, (Jan 4, 2017)

Transforming a trial from a clinical ‘experiment’ to a standard care option.
Market Access

Adapt or Die: Real-World Evidence Across the Lifecycle

Deirdre Coleman, (Dec 20, 2016)

The regulator’s view of real-world evidence

The Sales Rep of the Future

Dr Nicola Davies, (Dec 16, 2016)

Sales reps will need to update their skills to match customer needs

Time to Get Personal

Dr Nicola Davies, (Dec 15, 2016)

Are sales force incentives linked to drug sales volumes the best way to motivate individual sales reps?

Making the Patient-Centric Trial a Reality

Danielle Barron, (Dec 14, 2016)

Learn what a panel of experts had to say on how we can create value for patients in trials, keep them engaged, and treat them like gold.
Market Access

Mind the Gap

Adam Hill, (Dec 13, 2016)

The importance of real-world evidence in market access is growing, but what rules can pharma follow to close the evidence gaps?

Surviving the Tidal Wave

Dr Nicola Davies, (Dec 8, 2016)

Pharma needs new strategies in the face of a 'tidal wave' of costly and complex diseases.

Made to Measure

Danielle Barron, (Dec 7, 2016)

Pharma needs to measure the patient-centricity of its clinical trials as accurately as any other variable, says Professor Michael Howley

Engagement with Impact

Deirdre Coleman, (Dec 5, 2016)

Medical Science Liasions need more than just scientific acumen to get the message across.

Engaging Kids to Fight Malaria

Thomas Disley, (Dec 1, 2016)

An interview with the team behind the MOSKI KIT, a Sanofi tool against malaria.